Allogeneic Blood or Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis for Myelodysplastic Syndrome/Myeloproliferative Neoplasm-Overlap Syndromes (MDS/MPN)

被引：0
|
作者：
Karantanos, Theodoros
Tsai, Hua-Ling
Gondek, Lukasz P.
Levis, Mark
Showel, Margaret M.
DeZern, Amy E.
Gojo, Ivana
Varadhan, Ravi
Jones, Richard J.
Jain, Tania
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Post-transplantation cyclophosphamide compared to graft-versus-host disease prophylaxis with ATG in mismatched unrelated donor hematopoietic stem cell transplantation
    Soltermann, Yves
    Heim, Dominik
    Baldomero, Helen
    Medinger, Michael
    Halter, Jorg P.
    Passweg, Jakob P.
    Kleber, Martina
    BONE MARROW TRANSPLANTATION, 2018, 53 : 75 - 76
  • [32] INDIRECT ASSOCIATION OF ELEVATED SERUM IGE AND GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    DONNENBERG, AD
    HEYD, J
    BURNS, WH
    SARAL, R
    SANTOS, GW
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 517 - 517
  • [33] Post-Transplant Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis is Safe and Effective in Elderly Patients over Age 70 Years Undergoing Allogeneic (Allo) Stem Cell Transplantation (SCT)
    Nath, Rajneesh
    Kodali, Murali
    Kamal, Ashan
    Ulrickson, Matthew
    Go, Aileen
    Madan, Sumit
    Heers, Haley
    De Padova, Nicholas
    Miller, Richelle
    Mohammed, Reeshma
    Yasuda, Rachel
    Pebler, Haley
    Zhou, Zheng
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S537 - S538
  • [34] Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
    Queralt Salas, Maria
    Atenafu, Eshetu G.
    Datt Law, Arjun
    Lam, Wilson
    Pasic, Ivan
    Chen, Carol
    Kim, Dennis
    Michelis, Fotios, V
    Gerbitz, Armin
    Howard Lipton, Jeffrey
    Mattsson, Jonas
    Kumar, Rajat
    Viswabandya, Auro
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 428.e1 - 428.e9
  • [35] PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation
    Desai, Nihar
    Altareb, Majed
    Remberger, Mats
    Chen, Carol
    Moya, Tommy Alfaro
    Al-Shaibani, Eshrak
    Novitzky-Basso, Igor
    Pasic, Ivan
    Lam, Wilson
    Michelis, Fotios, V
    Gerbitz, Armin
    Viswabandya, Auro
    Kumar, Rajat
    Kim, Dennis Dong Hwan
    Lipton, Jeffrey H.
    Mattsson, Jonas
    Law, Arjun Datt
    BLOOD ADVANCES, 2025, 9 (03) : 660 - 669
  • [36] Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis
    Stastna-Markova, Marketa
    Pecherkova, Pavla
    Nemeckova, Sarka
    Krystofova, Jitka
    Vanikova, Sarka
    Vydra, Jan
    Roubalova, Katerina
    TRANSPLANT IMMUNOLOGY, 2025, 88
  • [37] Graft versus host disease prophylaxis with everolimus and tacrolimus in patients with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) receiving allogeneic peripheral blood stem cell transplantation (PBSCT).
    Platzbecker, Uwe
    Pabst, Caroline
    Kiani, Alexander
    Schetelig, Johannes
    Wermke, Martin
    Helwig, Anett
    Ehninger, Gerhard
    Bornhaeuser, Martin
    BLOOD, 2006, 108 (11) : 817A - 817A
  • [38] Phenotypic Myeloid-Derived Suppressor Cells (MDSCs) are expanded after Post-Transplantation Cyclophosphamide (PTCy), but are not necessary for Graft-Versus-Host Disease Prevention by PTCy
    Fletcher, Rochelle E.
    Nunes, Natalia S.
    Patterson, Michael T.
    Mendu, Suresh K.
    Khan, Shanzay M.
    Wachsmuth, Lucas P.
    Eckhaus, Michael A.
    Venzon, David J.
    Kanakry, Christopher G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S169 - S170
  • [39] Post-transplantation cyclophosphamide and cyclosporine A versus methotrexate and cyclosporine A for graft-versus-host disease prophylaxis after allogeneic peripheral stem cell transplantation in adult acute myeloid leukemia patients
    El-Deen, Mustafa O. Sharaf
    Soliman, Moetaza M.
    Al-Azab, Gamal
    Samra, Mohamed
    Shams, Mohammad E. E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 491
  • [40] Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
    Kanakry, Christopher G.
    O'Donnell, Paul V.
    Furlong, Terry
    de Lima, Marcos J.
    Wei, Wei
    Medeot, Marta
    Mielcarek, Marco
    Champlin, Richard E.
    Jones, Richard J.
    Thall, Peter F.
    Andersson, Borje S.
    Luznik, Leo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (31) : 3497 - +
12345